Abstract: Methods, apparatus, systems and articles of manufacture for federated training of a neural network using trusted edge devices are disclosed. An example system includes an aggregator device to aggregate model updates provided by one or more edge devices. The one or more edge devices to implement respective neural networks, and provide the model updates to the aggregator device. At least one of the edge devices to implement the neural network within a trusted execution environment.

Abstract: Methods, apparatus, systems and articles of manufacture are disclosed that provide an apparatus to analyze vehicle perspectives, the apparatus comprising a profile generator to generate a first profile of an environment based on a profile template and first data generated by a first vehicle; a data analyzer to: determine a difference between the first profile and a second profile obtained from a first one of one or more nodes in the environment; and in response to a trigger event, update the first profile based on the difference; and a vehicle control system to: in response to the trigger event, update a first perspective of the environment based on one or more of second data from the first one of the one or more nodes or the updated first profile; update a path plan for the first vehicle based on the updated first perspective; and execute the updated path plan.

Abstract: Disclosures herein may be directed to a method, technique, or apparatus directed to a computer-assisted or autonomous driving (CA/AD) vehicle that includes a system controller, disposed in a first CA/AD vehicle, to manage a collaborative three-dimensional (3-D) map of an environment around the first CA/AD vehicle, wherein the system controller is to receive, from another CA/AD vehicle proximate to the first CA/AD vehicle, an indication of at least a portion of another 3-D map of another environment around both the first CA/AD vehicle and the another CA/AD vehicle and incorporate the at least the portion of the 3-D map proximate to the first CA/AD vehicle and the another CA/AD vehicle into the 3-D map of the environment of the first CA/AD vehicle managed by the system controller.

Abstract: Methods, systems, articles of manufacture and apparatus to detect process hijacking are disclosed herein. An example apparatus to detect control flow anomalies includes a parsing engine to compare a target instruction pointer (TIP) address to a dynamic link library (DLL) module list, and in response to detecting a match of the TIP address to a DLL in the DLL module list, set a first portion of a normalized TIP address to a value equal to an identifier of the DLL. The example apparatus disclosed herein also includes a DLL entry point analyzer to set a second portion of the normalized TIP address based on a comparison between the TIP address and an entry point of the DLL, and a model compliance engine to generate a flow validity decision based on a comparison between (a) the first and second portion of the normalized TIP address and (b) a control flow integrity model.

Abstract: Technologies for configuring a two-dimensional (2D) semi-regular sparse array of sonar detector elements are disclosed. The 2D array may be formed from a non-uniform one-dimensional (1D) array of non-uniform arrays. The 2D array may be composed of two or more 1D arrays with non-uniform spacing patterns of sonar detector elements in a first direction arranged parallel relative to one another with a non-uniform spacing pattern between the 1D arrays forming a 1D array in a second direction. The output data from the array may be used as input for a beamforming technique.

Abstract: The present invention provides certain substituted chromane, isochromane, and dihydroisobenzofuran compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein ring A is a moiety selected from: and ring B, n, R1, R2, R2A, R3, and R3A are as defined herein. The compounds of the invention are useful as mGluR2 inhibitors, or mGluR2 negative allosteric modulators (NAMs), and may be useful in methods of treating a patient for diseases or disorders in which the mGluR2-NAM receptor is involved, such as Alzheimer's disease, cognitive impairment, mild congnitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders, by administering to the patient a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof.

Abstract: An improved method of treating a skin barrier condition is disclosed. The method involves identifying a target portion of skin on a person where treatment is desired and applying a low-pH composition to the target portion of skin. The low-pH composition contains an effective amount of a vitamin B3 compound and has a pH of less than 5.0.

Abstract: A method for accounting for carbon offsets realized by energy-efficient, electrically-powered devices used by electrical power consumers includes obtaining power usage data for the devices, calculating an initial power reduction attributable to the device, calculating a final power reduction accounting for line loss between the device's location and the location of the power generator. The final power reduction is converted to a carbon offset amount by considering the fuel type used by the power generator. Carbon offsets are then accounted for with distributed ledger technology. A system that performs the method is also disclosed.

Abstract: A method comprises receiving in a governor device, from a plurality of data owner devices, metadata for one or more datasets maintained by the plurality of data owner devices, registering the metadata for the one or more datasets with the governor device, in response to a request from an aggregator, providing at least a portion of the metadata for the one or more datasets to the aggregator, receiving, from the aggregator, a compute plan to be implemented by the plurality of data owner devices, distributing at least a portion of the compute plan to the plurality of data owner devices, in response to receiving, from the plurality of data owner devices, a verification report and a certification for an enclave, binding the enclave to a host device, and providing the compute plan to the plurality of data owner devices.

Abstract: The present invention discloses a secure ML pipeline to improve the robustness of ML models against poisoning attacks and utilizing data provenance as a tool. Two components are added to the ML pipeline, a data quality pre-processor, which filters out untrusted training data based on provenance derived features and an audit post-processor, which localizes the malicious source based on training dataset analysis using data provenance.

Abstract: Methods, apparatus, systems and articles of manufacture are disclosed. An example system includes a memory accessed by a program of interest, a performance monitoring unit to collect first memory access information and second memory access information about an object accessed in the memory by the program of interest; and a leak detector to: determine a non-access period based on the first memory access information and an unsupervised machine learning model trained based on the program of interest; and detect a potential memory leak of the program of interest based on the second memory access information and the non-access period.

Abstract: The present invention provides certain substituted chromane, isochromane, and dihydroisobenzofuran compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein ring A is a moiety selected from: and ring B, n, R1, R2, R2A, R3, and R3A are as defined herein. The compounds of the invention are useful as mGuR2 inhibitors, or mGluR2 negative allosteric modulators (NAMs), and may be useful in methods of treating a patient for diseases or disorders in which the mGuR2-NAM receptor is involved, such as Alzheimer's disease, cognitive impairment, mild cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders, by administering to the patient a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof.

Abstract: An apparatus includes a data interface to obtain first sensor data from a first sensor and second sensor data from a second sensor of a monitored system; a data analyzer to extract a feature based on analyzing the first and second sensor data using a model, the model trained based on historical sensor data, the model to determine the feature as a deviation between the first and second sensor data to predict a future malfunction of the monitored system; an anomaly detector to detect an anomaly in at least one of the first sensor data or the second sensor data based on the feature, the anomaly corresponding to the future malfunction of the monitored system; and a system applicator to modify operation of the monitored system based on the anomaly.

Abstract: A machine-readable medium comprises data which, if used by a computing system, causes the computing system to (a) determine a first environmental factor corresponding to a first location of a user; (b) determine a second environmental factor corresponding to an identity of the user; (c) access first and second preconfigured authorization policies in response to determining the first and second environmental factors, respectively; (d) determine first and third security access mechanisms in response to accessing the first authorization policy; (e) determine a second security access mechanism in response to accessing the second authorization policy; (f) allow the user access to a first module of the computing system when the user complies with both the first and third security access mechanisms; and (g) allow the user access to a second module in response to the user's compliance with the second security access mechanism. Other embodiments are described and claimed.

Abstract: In one embodiment, an apparatus includes: a bioimpedance sensor to generate bioimpedance information based on bioimpedance sample information from at least some of a plurality of electrodes to be adapted about a portion of a person; at least one biometric sensor to generate biometric information based on biometric sample information from at least some of the plurality of electrodes; at least one environmental sensor to generate environmental context data; and an integration circuit to receive the bioimpedance information, the biometric information and the environmental context data and to adjust the bioimpedance information based at least in part on a value of one or more of the biometric information and the environmental context data. Other embodiments are described and claimed.

Abstract: An embodiment includes a method executed by at least one processor comprising: determining a first environmental factor for a mobile communications device; determining a first security authentication level based on the determined first environmental factor; and allowing access to a first module of the mobile communications device based on the first security authentication level. Other embodiments are described herein.

Abstract: The present invention relates to compounds of general formula (I). wherein A represents an optionally substituted heterocycle group, B represents an aryl or heteroaryl group and wherein X, R1, R2, R3, R4 and R5 are as defined in the description. Compounds of formula (I) are useful to destroy, inhibit, or prevent the growth or spread of cells, especially malignant cells, into surrounding tissues implicated in a variety of human and animal diseases.

Abstract: An improved method of treating a skin barrier condition is disclosed. The method involves identifying a target portion of skin on a person where treatment is desired and applying a low-pH composition to the target portion of skin. The low-pH composition contains an effective amount of a vitamin B3 compound and has a pH of less than 5.0.

Abstract: Various embodiments are generally directed to an apparatus, method, and other techniques to maintain user authentications with common trusted devices. If a user is in possession of a first computing device (e.g., a smartphone), an unlocked state of the first trusted device is maintained if the user is using a nearby trusted device (e.g., a computer) within a certain amount of time. If the first trusted device is in a pocket or other container, a longer span of time is granted to the user to register an on-body state.

Abstract: A mechanism is described for facilitating context-based access control of resources for according to one embodiment. A method of embodiments, as described herein, includes receiving a first request to access a resource of a plurality of resources. The first request may be associated with one or more contexts corresponding to a user placing the first request at a computing device. The method may further include evaluating the one or more contexts. The evaluation of the one or more contexts may include matching the one or more contexts with one or more access policies associated with the requested resource. The method may further include accepting the first request if the one or more contexts satisfy at least one of the access policies.